Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma

Monson, Matthew; Stark, Paul C.; Reilly, John J.; Sugarbaker, David J.; Strauss, Gary M.; Swanson, Scott J.; DeCamp, Malcolm M.; Mentzer, Steven J.; Baldini, Mariella

doi:10.1002/(sici)1097-0142(19980301)82:5<842::aid-cncr7>3.0.co;2-l

Cited by 178 publications

(70 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Many studies report that smoking cessation after a diagnosis of lung cancer is associated with health improvements (table 4) [64][65][66][67][68][69][70][71][72][73][74][75][76][77][78][79][80][81][82][83].…”

Section: Benefits Of Smoking Cessation In Patients With Lung Cancermentioning

confidence: 99%

Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit

Jiménez-Ruíz¹,

et al. 2015

View full text Add to dashboard Cite

Chronic obstructive pulmonary disease (COPD), lung cancer, asthma and pulmonary tuberculosis are common pulmonary diseases that are caused or worsened by tobacco smoking. Growing observational evidence suggests that symptoms and prognosis of these conditions improve upon smoking cessation. Despite increasing numbers of (small) randomised controlled trials suggesting intensive smoking cessation treatments work in people with pulmonary diseases many patients are not given specific advice on the benefits or referred for intensive cessation treatments and, therefore, continue smoking. This is a qualitative review regarding smoking cessation in patients with COPD and other pulmonary disorders, written by a group of European Respiratory Society experts. We describe the epidemiological links between smoking and pulmonary disorders, the evidence for benefits of stopping smoking, how best to assess tobacco dependence and what interventions currently work best to help pulmonary patients quit. Finally, we describe characteristics and management of any "hardcore" smoker who finds it difficult to quit with standard approaches. @ERSpublications Smoking cessation is crucial for respiratory patients: every patient must be given advice and help to quit http://ow.ly/ITgsW

show abstract

Section: Benefits Of Smoking Cessation In Patients With Lung Cancermentioning

confidence: 99%

Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit

Jiménez-Ruíz¹,

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Chronic airway inflammation, impaired mucociliary clearance, impaired growth of the lungs during childhood, and increased bronchial hyperresponsiveness are all enhanced by smoking. 82,83,55 Immunologic mechanisms include effects on T cell function and a higher ratio of Th2/Th1, increased production of IgE, and greater allergic sensitization. Cigarette smoke may increase neurogenic inflammation in the bronchial airway 84,85 resulting in further inflammation of the airway.…”

Section: 67mentioning

confidence: 99%

Tobacco dependence; the whole story

Hawari

2018

Int. J. Hum. Health Sci.

View full text Add to dashboard Cite

Abstract:The use of tobacco dates back to hundreds of years and is considered highly addictive. Nicotine is the predominant substance that causes tobacco dependence. Nicotine exerts its effect via similar neurological pathways used by other recreational drugs resulting in high level of dependence. All forms of exposure to tobacco including active use of tobacco, second-hand as well as third-hand exposure to tobacco smoke are known to be harmful. Tobacco is the only risk factor that is common between all non-communicable diseases including cardiovascular diseases, respiratory illnesses, cancer and diabetes mellitus. International consensus regarding the harms of tobacco is now evident. Many international organizations are mapping the way for the end of tobacco. Until then, aggressive treatment for those subjects interested in quitting must be provided in order to prevent a significant surge in non-communicable diseases especially in low income countries. Tobacco dependence is a chronic relapsing disorder that requires a multidisciplinary approach using psychological and pharmacological techniques.

show abstract

“…In a study of women who underwent pelvic radiation therapy for stage I or II carcinoma of the cervix, smoking one or more packs of cigarettes per day was the strongest predictor of small bowel complications (35). In addition, smoking history was a major risk factor for radiation pneumonitis after therapy for lung cancer (36).…”

Section: Effects Of Smoking On Cancer Treatment and Outcomementioning

confidence: 99%

Smoking, The Missing Drug Interaction in Clinical Trials: Ignoring the Obvious

Gritz

Dresler²,

Sarna

2005

Cancer Epidemiology, Biomarkers &Amp; Prevention

177

156

View full text Add to dashboard Cite

Tobacco use is universally recognized as the foremost preventable cause of cancer in the United States and globally and is responsible for 30% of all cancer-related deaths in the United States. Tobacco use, including exposure to secondhand smoke has been implicated as a causal or contributory agent in an ever-expanding list of cancers, including lung, oral cavity and pharynx, pancreas, liver, kidney, ureter, urinary bladder, uterine cervix, and myeloid leukemia. In addition to and independent of the etiologic effects of tobacco carcinogens in numerous cancers, there is a growing literature on the direct and indirect effects of smoking on treatment efficacy (short-term and long-term outcomes), toxicity and morbidity, quality of life (QOL), recurrence, second primary tumors (SPT), and survival time as summarized below. Oncology health professionals have called for increased advocacy for tobacco control. Despite the critical relevance of smoking to cancer outcomes, most oncology clinical trials do not collect data on smoking history and status unless the malignancy is widely acknowledged as smoking related (e.g

show abstract

Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma

Cited by 178 publications

References 37 publications

Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit

Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit

Tobacco dependence; the whole story

Smoking, The Missing Drug Interaction in Clinical Trials: Ignoring the Obvious

Contact Info

Product

Resources

About